Lactation suppression

Area of Science:

• Reproductive Endocrinology
• Pharmacology

Background:

• Lactation involves complex hormonal regulation by prolactin and oxytocin.
• Postpartum lactation suppression is necessary for a significant portion of women.
• Estrogen and progesterone withdrawal postpartum initiates milk secretion.

Purpose of the Study:

• To review current methods for postpartum lactation suppression.
• To evaluate the efficacy and risks of different suppression strategies.

Main Methods:

• Review of existing literature on lactation suppression mechanisms and treatments.
• Analysis of hormonal therapies including estrogen, androgens, and bromocriptine.
• Assessment of injectable hormone combinations for postpartum use.

Main Results:

• Mechanical suppression (tight brassiere, avoiding stimulation) is effective in 60-70% of cases.
• Estrogen and androgen combinations achieve up to 90% suppression but carry risks like rebound lactation and thromboembolism.
• Bromocriptine is safe and effective but requires a 2-week therapy period.
• A single injection of testosterone enanthate and estradiol valerate is effective and low-risk for immediate postpartum suppression.

Conclusions:

• Hormonal therapies offer effective postpartum lactation suppression.
• Injectable hormone combinations provide a safe and efficient alternative to oral medications.
• Further research may be needed to optimize long-term safety profiles of hormonal suppression.